Search
Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.
MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers.
A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe.
TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.
Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.
Learn about MSK thoracic surgeon Valerie Rusch and her approach to treating people with lung cancer and other tumors of the chest.
Research shows that TIL therapy, an emerging type of immunotherapy, works in some patients with non-small cell lung cancer.
Las investigaciones muestran que la terapia LIT, un tipo emergente de inmunoterapia, funciona en algunos pacientes con cáncer pulmonar de células no pequeñas.
MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.
In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.